Hackensack Meridian Health
Clinical trials sponsored by Hackensack Meridian Health, explained in plain language.
-
New drug combo tested for Tough-to-Treat blood cancer
Disease control TerminatedThis study is testing whether adding a drug called selinexor to existing multiple myeloma treatments can help patients whose cancer has returned or stopped responding to their current therapy. The trial involves 96 adults with multiple myeloma that has progressed despite treatmen…
Phase: PHASE2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New drug cocktail aims to tame tough blood cancer
Disease control OngoingThis study is testing a combination of four drugs (carfilzomib, lenalidomide, vorinostat, and dexamethasone) for adults with multiple myeloma that has returned or stopped responding to prior treatment. The main goals are to find the safest dose and see if this powerful combinatio…
Phase: PHASE1, PHASE2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Scientists test Triple-Threat drug cocktail for Tough-to-Treat blood cancer
Disease control OngoingThis early-stage study aims to find the safest and most effective dose of a three-drug combination (ibrutinib, lenalidomide, and rituximab) for adults with mantle cell lymphoma that has returned or stopped responding to prior treatment. The main goal is to see how much of the new…
Phase: PHASE1 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
New test could predict amputation risk after leg artery surgery
Diagnosis TerminatedThis study aimed to test if a new measurement of tiny blood vessel function could predict whether a patient's leg could be saved after a procedure to open blocked arteries. It focused on patients with severe leg artery disease who were at high risk of amputation. The goal was to …
Phase: NA • Sponsor: Hackensack Meridian Health • Aim: Diagnosis
Last updated Mar 02, 2026 15:24 UTC
-
Study asks: can some newborns skip breathing support machines?
Knowledge-focused OngoingThis small pilot study is testing whether full-term newborns with mild breathing difficulties can safely manage without a common breathing support machine called CPAP. Researchers are closely watching 22 babies born via scheduled C-section to see if careful observation alone is s…
Phase: EARLY_PHASE1 • Sponsor: Hackensack Meridian Health • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:24 UTC